SCHADE CHRISTIAN S, CEO of APRE - Past Performance as of 10/15/19. Total 11 Records. Link to Thomson Financial
Buy(P) /
Sell(S)
P/S date Filed Date Company Symbol Insider Relationship Share Amt. Unit Price Total Proceeds Shares Owned Return(1m) Details
P 2019-10-07 2019-10-07 19:15:56.0 Aprea Therapeutics, Inc. APRE SCHADE CHRISTIAN S CEO 1,000 $15.00 $15,000.00 1,000 view
P 2019-10-07 2019-10-07 19:15:56.0 Aprea Therapeutics, Inc. APRE SCHADE CHRISTIAN S CEO 1,000 $15.00 $15,000.00 1,000 view
P 2019-10-07 2019-10-07 19:15:56.0 Aprea Therapeutics, Inc. APRE SCHADE CHRISTIAN S CEO 1,000 $15.00 $15,000.00 1,000 view
P 2019-10-07 2019-10-07 19:15:56.0 Aprea Therapeutics, Inc. APRE SCHADE CHRISTIAN S CEO 1,000 $15.00 $15,000.00 1,000 view
P 2019-10-07 2019-10-07 19:15:56.0 Aprea Therapeutics, Inc. APRE SCHADE CHRISTIAN S CEO 1,000 $15.00 $15,000.00 1,000 view
P 2019-10-07 2019-10-07 19:15:56.0 Aprea Therapeutics, Inc. APRE SCHADE CHRISTIAN S CEO 1,000 $15.00 $15,000.00 1,000 view
P 2019-10-07 2019-10-07 19:15:56.0 Aprea Therapeutics, Inc. APRE SCHADE CHRISTIAN S CEO 5,000 $15.00 $75,000.00 5,000 view
S 2019-05-10 2019-05-14 16:21:22.0 INTEGRA LIFESCIENCES HOLDINGS CORP IART SCHADE CHRISTIAN S director 15,658 $51.56 $807,328.00 32,633 view
S 2018-03-05 2018-03-06 16:19:18.0 INTEGRA LIFESCIENCES HOLDINGS CORP IART SCHADE CHRISTIAN S director 15,658 $52.88 $827,987.00 29,668 view
S 2016-05-03 2016-05-05 16:21:36.0 INTEGRA LIFESCIENCES HOLDINGS CORP IART SCHADE CHRISTIAN S director 7,829 $70.42 $551,311.00 10,721 N/A view
S 2014-02-28 2014-02-28 17:41:02.0 INTEGRA LIFESCIENCES HOLDINGS CORP IART SCHADE CHRISTIAN S director 7,500 $47.06 $352,922.00 11,902 3.94% view
* Filed by insider as open market transaction, but marked as private transaction by insidercow's proprietary method